This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Medical 21, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Jeff R Vreeman: Innovator in Biodegradable Implants
Introduction
Jeff R Vreeman is an accomplished inventor based in Brooklyn Park, MN (US). He has made significant contributions to the field of medical technology, particularly in the development of innovative implant solutions. His work focuses on enhancing the body's natural healing processes through advanced materials.
Latest Patents
Vreeman holds a patent for a composite implant that features multiple open-pore biodegradable polymer layers. These layers are mechanically supported by a permanent structure positioned between adjacent polymer layers. This design drives a native response for cellular infiltration, facilitating progressive cellular-driven remodeling, cellular organization, and native extra-cellular matrix (ECM) deposition. The implant is engineered to undergo endogenous tissue remodeling over time, with the polymer layers fully degrading, leaving only the new native tissue supported by the permanent structure. This innovative approach ensures that the implant can effectively carry mechanical loads while the remodeling process is ongoing.
Career Highlights
Jeff R Vreeman is associated with Medical 21, Inc., where he continues to push the boundaries of medical technology. His work has garnered attention for its potential to improve patient outcomes through advanced implant designs.
Collaborations
Vreeman collaborates with notable colleagues, including Chaid D Schwarz and Eric E Solien, who contribute to the innovative environment at Medical 21, Inc.
Conclusion
Jeff R Vreeman's contributions to the field of biodegradable implants exemplify the intersection of innovation and medical technology. His patented work not only enhances the healing process but also represents a significant advancement in implant design.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile